News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

FDA simplifies Institutional Review Board review requirements for physicians seeking individual patient expanded access - Drug Information Update

Al's Comment:

 The FDA issued 3 new guidence documents relating to expanded access of experimental drugs.  This makes it a lot easier for your doctor to get permission to use them. Big step, but not enough.  


Posted on: 10/03/2017

FDA simplifies Institutional Review Board review requirements for physicians seeking individual patient expanded access - Drug Information Update

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites



Musella Foundation For Brain Tumor Research & Information, Inc